Plamotamab (XmAb ® 13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia.

Authors :: Parrondo RD
Paulus A
Alegria V
Liebowitz D
Johnson C
Clynes R
Roy V
Menke DM
Jiang L
Chanan-Khan AA
Ailawadhi S
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2022 Mar; Vol. 63 (3), pp. 738-742. Date of Electronic Publication: 2021 Nov 16.
Publication Year :: 2022

Subjects :: Adenine analogs & derivatives
Humans
Myeloid Differentiation Factor 88 genetics
Piperidines
Receptors, CXCR4 genetics
Waldenstrom Macroglobulinemia diagnosis
Waldenstrom Macroglobulinemia drug therapy
Waldenstrom Macroglobulinemia genetics

Full Text Access

Tools